LOGO
LOGO

Newly Listed BioAge Labs To Present At Investor Conferences, Expects Obesity Trial Data By Q3 2025

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

BioAge Labs Inc. (BIOA), a clinical-stage biopharmaceutical company developing therapies for metabolic diseases by targeting the biology of aging, is scheduled to participate in two major investor conferences next month, i.e., on Dec.3 and Dec.4.

The company CEO and co-founder, Kristen Fortney, will lead the presentation, followed by one-on-one meetings with investors.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

RELATED NEWS
Latest Updates on COVID-19